Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;41(6):395-402.
doi: 10.1007/s10735-010-9301-7. Epub 2010 Oct 20.

Protective effect of quercetin on liver damage induced by biliary obstruction in rats

Affiliations

Protective effect of quercetin on liver damage induced by biliary obstruction in rats

Mehmet Kanter. J Mol Histol. 2010 Dec.

Abstract

The aim of this study was to evaluate the possible protective effects of quercetin (QE) against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. A total of 24 male Wistar albino rats were divided into three groups: control, bile duct ligation (BDL) and BDL + received QE; each group contain 8 animals. The rats in QE treated groups were given QE (15 mg/kg) once a day intraperitoneally for 4 weeks starting 3 days prior to BDL operation. The changes demonstrating the bile duct proliferation and fibrosis in expanded portal tracts include the extension of proliferated bile ducts into lobules, mononuclear cells, and neutrophil infiltration into the widened portal areas were observed in BDL group. Treatment of BDL with QE attenuated alterations in liver histology. The alpha smooth muscle actin (α-SMA), transforming growth factor beta (TGF-β1) positive cells and the activity of TUNEL in the BDL were observed to be reduced with the QE treatment. The data indicate that QE attenuates BDL-induced cholestatic liver injury, bile duct proliferation, and fibrosis. The hepatoprotective effect of QE is associated with antioxidative potential.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Methods Enzymol. 1990;186:343-55 - PubMed
    1. J Hepatol. 1995 Jun;22(6):696-9 - PubMed
    1. Biochem Pharmacol. 1991 Oct 9;42(9):1673-81 - PubMed
    1. Neurosci Lett. 2008 Jun 13;438(1):90-5 - PubMed
    1. Kidney Int. 2004 Jul;66(1):112-20 - PubMed

LinkOut - more resources